Physician profile
Eric C Lai
NPI 1104082783
$4,686.44
in general payments reported to CMS, 2019-2025
15 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2021: $1,054 · 2022: $902 · 2023: $686 · 2024: $565 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,315.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $908.44 | 2021-2022 | |
| Mentor Worldwide LLC | $678.08 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $595.07 | 2021-2024 | |
| Davol INC. | $511.75 | 2022-2025 | Phasix Mesh, Arista |
| Abbvie INC. | $432.00 | 2023-2025 | |
| Rti Surgical, INC | $259.33 | 2024-2025 | |
| Tepha INC | $254.35 | 2019 | |
| Mesh Suture INC | $194.01 | 2024 | |
| Baxter Healthcare | $166.68 | 2019-2025 | |
| Integra Lifesciences Corporation | $166.45 | 2023 | Durasorb Monofilament Mesh |
| Tela Bio, INC. | $160.28 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Biocircuit Technologies INC | $157.52 | 2025 | Nerve Tape |
| Polynovo North America LLC | $155.99 | 2022 | |
| Allergan, INC. | $26.15 | 2021 | |
| Cranial Technologies, INC | $20.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.